New hope for rare muscle disease: drug trial targets inflammation
NCT ID NCT06536166
First seen Nov 01, 2025 · Last updated Apr 30, 2026 · Updated 26 times
Summary
This study tests a drug called ruxolitinib in 80 adults with inclusion body myositis, a rare disease that causes progressive muscle weakness. The goal is to see if blocking a specific immune signal can help patients walk farther in 6 minutes. Researchers will also check for side effects and measure muscle strength changes.
Disclaimer
Read more
Show less
This is a summary of
the original study
.
Summaries may miss details or leave out important information. Before applying or accepting participation, make sure you have read and understood the full study. Curemydisease.com takes no responsibility whatsoever for anything missed, misunderstood, or acted upon as a result of our summary — we know it does not capture everything.
This is a summary of the original study . Summaries may miss details or leave out important information. Before applying or accepting participation, make sure you have read and understood the full study. Curemydisease.com takes no responsibility whatsoever for anything missed, misunderstood, or acted upon as a result of our summary — we know it does not capture everything.
Get updates
Get notified about this study
Sign up to get updates when this study changes or when new studies for INCLUSION BODY MYOSITIS, SPORADIC are added.
Genom att skicka in godkänner du våra Användarvillkor
Contacts and locations
Show contact details
Enter your email to view the contact information for this study.
Genom att skicka in godkänner du våra Användarvillkor
Study contacts
-
Contact
Phone: •••-•••-•••• Email: •••••@•••••
Locations
-
CHU Caen Normandie
ACTIVE_NOT_RECRUITINGCaen, France, 14000, France
-
CHU Nancy
ACTIVE_NOT_RECRUITINGNancy, France, 54035, France
-
Hôpital Bellevue, CHU Saint-Etienne
ACTIVE_NOT_RECRUITINGSaint-Etienne, France, 42270, France
-
Hôpital Christian Cabrol, CHU Reims
ACTIVE_NOT_RECRUITINGReims, France, 51100, France
-
Hôpital Dupuytren, CHU de Limoges
ACTIVE_NOT_RECRUITINGLimoges, France, 87000, France
-
Hôpital Henri-Mondor, APHP
RECRUITINGCréteil, France, 94010, France
Contact Phone: •••-•••-•••• Email: •••••@•••••
-
Hôpital Pasteur, CHU de Nice
RECRUITINGNice, France, 06001, France
Contact Phone: •••-•••-•••• Email: •••••@•••••
-
Hôpital Pellegrin - Tripode, CHU de Bordeaux
ACTIVE_NOT_RECRUITINGBordeaux, France, 33076, France
-
Hôpital Pierre Wertheimer, CHU de Lyon
ACTIVE_NOT_RECRUITINGBron, France, 69500, France
-
Hôpital Pierre-Paul Riquet, CHU de Toulouse
NOT_YET_RECRUITINGToulouse, France, 31059, France
Contact Phone: •••-•••-•••• Email: •••••@•••••
-
Hôpital Pitié-Salpêtrière, APHP
ACTIVE_NOT_RECRUITINGParis, France, 75013, France
-
Hôpital Raymond Poincaré, APHP
ACTIVE_NOT_RECRUITINGGarches, France, 92380, France
-
Hôpital Roger Salengro, CHU de Lille
NOT_YET_RECRUITINGLille, France, 59037, France
Contact Phone: •••-•••-•••• Email: •••••@•••••
-
Hôpital de Hautepierre, Hôpitaux Universitaires de Strasbourg
NOT_YET_RECRUITINGStrasbourg, France, 67089, France
Contact Phone: •••-•••-•••• Email: •••••@•••••
-
Hôpital de la Timone, APHM
NOT_YET_RECRUITINGMarseille, France, 13005, France
Contact Phone: •••-•••-•••• Email: •••••@•••••
-
Hôtel-Dieu, CHU Nantes
NOT_YET_RECRUITINGNantes, France, 44093, France
Contact Phone: •••-•••-•••• Email: •••••@•••••
Conditions
Explore the condition pages connected to this study.